Table 2.
Assess disease burden and risk factors |
Burden of congenital Chagas disease; role of autochthonous transmission |
Burden of cardiac disease caused by Trypanosoma cruzi and risk factors for severe sequelae among persons infected |
Burden of visceral toxocariasis and natural history of disease |
Burden of neurocysticercosis |
Trichomoniasis and increased risk of HIV and adverse outcomes of pregnancy |
Role of Toxoplasma gondii infection in psychiatric diseases |
Role of toxocariasis in allergic diseases |
Improved diagnostic tests and treatments |
Chagas disease tests and drugs |
Drug-resistant trichomoniasis: alternative drugs, better test to determine resistance |
Antibody tests using recombinant antigens to better identify active neurocysticercosis and monitor response to treatment |
Evaluation of drug regimens for treatment of pregnant women with acute toxoplasmosis |
Appropriate treatment of various manifestations of neurocysticercosis |
Optimal treatment for visceral and ocular toxocariasis |
Programmatic expansion of proven interventions |
Screening and treating contacts of neurocysticercosis cases for taeniasis |
Deworming of dogs and cats |
Covering sand boxes to reduce exposure to animal feces |
Health education to prevent toxoplasmosis: cooking meat adequately, pregnant women avoiding contact with cat litter |
Appropriate clinical management to prevent Chagas disease progression |
Treatment of male partners of women who have trichomoniasis |
HIV = human immunodeficiency virus.